Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03539705 · ClinicalTrials.gov registry record

Food Allergy Registry at a Single Site

A clinical trial of Allergy and Asthma, sponsored by Stanford University.

Recruiting
Registry status
6,000
Enrollment target
1
Study location

NCT03539705: Recruiting study of Allergy and Asthma, sponsored by Stanford University.

NCT03539705 is a study of Allergy and Asthma that is actively recruiting participants, run by Stanford University. The registered enrollment target is 6,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03539705, a study of Allergy and Asthma, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
6,000 participants
Enrollment target
1
Study location

Study Summary

This is a registry of participants who are interested in being screened for clinical trials at a single site.

Primary Outcome

The clinical trials could be either allergy or asthma studies

Conditions Studied

Interventions

  • OTHER There is no intervention

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 6,000 participants
Start Date 2018-01-05
Est. Completion 2028-05
Stanford University

1,744 total trials

What NCT03539705 shows while recruiting

NCT03539705 is an observational study that tracks outcomes without assigning an intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Allergy and Asthma appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention is the first listed.

NCT03539705 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03539705 about?

NCT03539705 is a clinical study titled "Food Allergy Registry at a Single Site". This is a registry of participants who are interested in being screened for clinical trials at a single site.

What is the current status of trial NCT03539705?

This trial is currently recruiting. The enrollment target is 6,000 participants. The study started on 2018-01-05. Estimated completion is 2028-05.

What conditions does trial NCT03539705 study?

This clinical trial studies the following conditions: Allergy and Asthma.

What interventions are being tested in trial NCT03539705?

The interventions under investigation include: There is no intervention (OTHER).

Who is sponsoring clinical trial NCT03539705?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03539705 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00005095 · 6,000 participants

    Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

  • NCT00280202 · 6,000 participants

    Detection of Genetic Markers of Lung Cancer

  • NCT03127631 · 6,000 participants · NA

    A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

  • NCT04324619 · 6,000 participants · NA

    iLookOut for Child Abuse: Micro-learning to Improve Knowledge Retention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03539705, the US trial registry maintained by the National Library of Medicine. NCT03539705 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.